🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study aims to investigate bacteriological efficacy of a nitrofurantoin ...
Status
Completed
Location
Cif Biotec, Medica Sur
Start Date
2007-01
Trial ID
NCT01092351
Treatments Being Tested
When patients are going to have surgery to remove large kidney stones (perc...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2015-03
Trial ID
NCT02384200
This study will investigate the effects of cranberry and quillaja capsules ...
Status
Terminated
Location
St. Joseph's Health Care London
Start Date
2021-01-01
Trial ID
NCT04496726
Treatments Being Tested
The objective of this study was to evaluate the relative bioavailability of...
Status
Completed
Location
Kendle International Inc.
Start Date
2003-09
Trial ID
NCT00649506
Treatments Being Tested
This phase 1b study is a double-blind, double-dummy, nitrofurantoin-control...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-05-18
Trial ID
NCT05138822
Treatments Being Tested
The study will be conducted to evaluate the therapeutic response (combined ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-04-23
Trial ID
NCT04187144
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
Kendle International Inc.
Start Date
2002-10
Trial ID
NCT00649285
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan ...
Status
Completed
Location
Kendle International Inc.
Start Date
2002-07
Trial ID
NCT01018342
Treatments Being Tested
An open label, randomised, two-treatment, four-period, two-sequence, single...
Status
Completed
Location
Ranbaxy Research Laboratories
Start Date
2003-09
Trial ID
NCT00778583
Treatments Being Tested
The study will be conducted to evaluate the therapeutic response (combined ...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-10-17
Trial ID
NCT04020341
Treatments Being Tested